Drug maker TaiGen Biotechnology Co (太景生技) is set to debut its shares on the Emerging Stock Market by the end of this month and plans to use the initial public offering (IPO) proceeds to finance clinical trials of its drugs, the company said yesterday.
The Cayman Island-registered company plans to issue 652 million shares, each with par value of US$0.001, said chief financial officer Max Chan (詹孟恭). The firm plans to set its IPO price before Monday next week, he said.
Founded in 2001, the company currently has three new drugs in its pipeline — Nemonnoxacin, Burixafor and TG-2349. Nemonnoxacin is an antibiotic and Burixafor is used to mobilize a leukemia patient’s stem cells and TG-2349 is used to cure hepatitis C, according to the company.
Burixafor completed the phase two clinical trials in the US, and TG-2349 is under phase one and two clinical trials in both the US and Taiwan, the company said, adding that Nemonnoxacin is currently under review for new drug application in China.
Nemonnoxacin is expected to obtain its Chinese drug permit in the first half of next year, with the patent lasting till 2029, it said.
In addition, the oral formulation of Nemonoxacin was licensed to China-based Zhejiang Medicine Co (浙江醫藥集團) for US$8 million and royalties of 7 percent to 11 percent on future sales of the drug.
The government owns 31.82 percent shares in TaiGen through various state entities, while YFY Group (永豐餘集團) holds 35.76 percent, with other shareholders, including Shin Kong Life Insurance (新光人壽) and Cathay Life Insurance (國泰人壽) holding the remainder, according to TaiGen.
CHIP RACE: Three years of overbroad export controls drove foreign competitors to pursue their own AI chips, and ‘cost US taxpayers billions of dollars,’ Nvidia said China has figured out the US strategy for allowing it to buy Nvidia Corp’s H200s and is rejecting the artificial intelligence (AI) chip in favor of domestically developed semiconductors, White House AI adviser David Sacks said, citing news reports. US President Donald Trump on Monday said that he would allow shipments of Nvidia’s H200 chips to China, part of an administration effort backed by Sacks to challenge Chinese tech champions such as Huawei Technologies Co (華為) by bringing US competition to their home market. On Friday, Sacks signaled that he was uncertain about whether that approach would work. “They’re rejecting our chips,” Sacks
It is challenging to build infrastructure in much of Europe. Constrained budgets and polarized politics tend to undermine long-term projects, forcing officials to react to emergencies rather than plan for the future. Not in Austria. Today, the country is to officially open its Koralmbahn tunnel, the 5.9 billion euro (US$6.9 billion) centerpiece of a groundbreaking new railway that will eventually run from Poland’s Baltic coast to the Adriatic Sea, transforming travel within Austria and positioning the Alpine nation at the forefront of logistics in Europe. “It is Austria’s biggest socio-economic experiment in over a century,” said Eric Kirschner, an economist at Graz-based Joanneum
BUBBLE? Only a handful of companies are seeing rapid revenue growth and higher valuations, and it is not enough to call the AI trend a transformation, an analyst said Artificial intelligence (AI) is entering a more challenging phase next year as companies move beyond experimentation and begin demanding clear financial returns from a technology that has delivered big gains to only a small group of early adopters, PricewaterhouseCoopers (PwC) Taiwan said yesterday. Most organizations have been able to justify AI investments through cost recovery or modest efficiency gains, but few have achieved meaningful revenue growth or long-term competitive advantage, the consultancy said in its 2026 AI Business Predictions report. This growing performance gap is forcing executives to reconsider how AI is deployed across their organizations, it said. “Many companies
France is developing domestic production of electric vehicle (EV) batteries with an eye on industrial independence, but Asian experts are proving key in launching operations. In the Verkor factory outside the northern city of Dunkirk, which was inaugurated on Thursday, foreign specialists, notably from South Korea and Malaysia, are training the local staff. Verkor is the third battery gigafactory to open in northern France in a region that has become known as “Battery Valley.” At the Automotive Energy Supply Corp (AESC) factory near the city of Douai, where production has been under way for several months, Chinese engineers and technicians supervise French recruits. “They
RSS